CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Neuroscience Startups (947)
Alzeca Biosciences develops imaging compounds to diagnose Alzheimer's disease at the earliest stages. Early detection of Alzheimer's is critical as disease pathology begins to accumulate 10+ years prior to cognitive onset of the disease. As a result,...Show all
Company (Alive / Active)
Phone:
1800 Bering Drive
#430
Houston, 77057
Texas, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Alzeca Biosciences | $11M | Aug 17, 2017 |
| Satoris | $5.2M | Nov 22, 2010 |
| Avid Radiopharmaceuticals | $68.4M | Nov 8, 2010 |
| See all 17 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Name | Firm |
|---|---|
| Login to see details | Chemwerth |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Lipid-based nanoparticles | Oct 30, 2017 | Nov 13, 2018 | Patent |
| Functionalized liposomes for imaging misfolded proteins | Jan 24, 2020 | Application |
